> For the complete documentation index, see [llms.txt](https://www.brexatlas.org/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.brexatlas.org/bre-001/bre-032.md).

# BRE 032

## Time-Varying Electromagnetic Fields and T-Type Calcium-Channel Cancer Suppression

**Clinical Focus:** Multi-Cancer Experimental Models

**Common Focus:** How Specific Electromagnetic Patterns May Slow Cancer Cell Growth

## Source

Buckner, C. A., Buckner, A. L., Koren, S. A., Persinger, M. A., & Lafrenie, R. M. (2015).

*Inhibition of Cancer Cell Growth by Exposure to a Specific Time-Varying Electromagnetic Field Involves T-Type Calcium Channels.*

*PLOS ONE, 10(4), e0124136.*

***

## BRS Score

**BRS:** 9.0 / 10\
**STEMD:** S9 / T8 / E9 / M10 / D9\
**External Evidence Level:** Moderate–High experimental in-vitro and in-vivo evidence

## Score Interpretation

BRE-032 receives a very strong BRS because it provides experimental evidence that specific time-varying electromagnetic field patterns inhibited malignant-cell proliferation through T-type calcium-channel-mediated signaling. The study included in-vitro validation, in-vivo validation, and waveform-response analysis.

***

## Entry Summary

BRE-032 asks a key bioelectric oncology question:

Can specific electromagnetic field patterns selectively inhibit cancer-cell growth by acting through calcium channels?

This study found that specific time-varying EMF exposure inhibited malignant-cell proliferation and that T-type calcium channels mediated the response.

In simple language:

Cancer cells may respond to certain electromagnetic patterns through calcium channels. When those channels are activated in the right way, cancer-cell growth may slow.

***

## What BREXAtlas Found

BREXAtlas identifies this primary mechanism chain:

Time-varying EMF\
↓\
T-type calcium-channel activation\
↓\
Calcium influx\
↓\
Cell-cycle disruption\
↓\
Reduced malignant proliferation

A secondary mechanism chain is:

Pattern-specific EMF exposure\
↓\
Selective malignant-cell response\
↓\
Altered intracellular signaling\
↓\
Tumor suppression

This makes BRE-032 one of the strongest entries supporting calcium-channel-based electromagnetic response as a real experimental pathway.

***

## Questions This BRE Helps Answer

<details>

<summary>What are T-type calcium channels?</summary>

T-type calcium channels are pathways that allow calcium to enter cells.

Calcium is a major signal inside the cell. When calcium flow changes, cell behavior can change.

What BREXAtlas found:\
BRE-032 supports that T-type calcium channels may mediate the cancer-cell response to specific time-varying EMF patterns.

</details>

<details>

<summary>Did cancer cells respond differently than normal cells?</summary>

What BREXAtlas found:\
Yes.

The extraction identifies stronger malignant-cell sensitivity than nonmalignant-cell sensitivity.

This matters because selective vulnerability is one of the most important questions in bioelectric oncology.

</details>

<details>

<summary>Is the exact EMF pattern important?</summary>

What BREXAtlas found:\
Yes.

BRE-032 identifies pattern-specific electromagnetic calcium activation and waveform-dependent tumor suppression as key mechanisms.

This means the effect should not be generalized to all EMF exposure.

</details>

***

## Study Classification

| Category                                   | Classification                                         |
| ------------------------------------------ | ------------------------------------------------------ |
| Study Type                                 | Experimental electromagnetic calcium-channel study     |
| Tissue Category                            | Breast carcinoma; melanoma; cervical cancer            |
| Cell Lines / Models                        | MDA-MB-231, MCF-7, HeLa, B16-BL6, HBL-100, HEK293, HSG |
| Exposure Type                              | Specific time-varying EMF                              |
| Direct TTFields Evidence                   | No                                                     |
| Direct Calcium-Channel Evidence            | Yes                                                    |
| Direct In-Vivo Evidence                    | Yes                                                    |
| Suitable for Frequency / Waveform Index    | Yes                                                    |
| Suitable for Calcium / Ion-Channel Index   | Yes                                                    |
| Suitable for Selective Vulnerability Index | Yes                                                    |

***

## Cell Lines / Models

BRE-032 identified:

* MDA-MB-231
* MCF-7
* HeLa
* B16-BL6
* HBL-100
* HEK293
* HSG

This makes the entry especially important because it compares malignant and nonmalignant response patterns across multiple cell systems.

***

## Mechanisms

**MEC-027: Voltage-Gated Ion Channel Activation**

Specific time-varying EMF patterns may activate T-type calcium channels.

**MEC-028: Calcium Overload / Calcium-Driven Cytotoxicity**

Calcium influx may contribute to reduced malignant proliferation.

**MEC-030: Ion-Channel Oncogenic Signaling**

Ion-channel signaling may influence tumor-cell growth and cell-cycle behavior.

**MEC-041: Pattern-Specific Electromagnetic Calcium Activation**

BRE-032 supports the idea that waveform structure matters and that not all EMF exposure is biologically equivalent.

**MEC-086: Waveform-Dependent Tumor Suppression**

The biological effect may depend on the structure of the electromagnetic waveform.

**MEC-087: Malignant-Cell Selective Inhibition**

Cancer cells may respond more strongly than nonmalignant cells under certain EMF exposure patterns.

***

## Discoveries

**DISC-016: Voltage-Gated Calcium Antenna Systems**

BRE-032 strongly supports the discovery that voltage-gated calcium channels may function as biological response points for electromagnetic exposure.

**DISC-018: Time-Varying EMF Calcium-Channel Selectivity**

BREXAtlas identifies this as a major discovery:

Specific time-varying EMF patterns may selectively inhibit malignant cells through calcium-channel-mediated signaling.

***

## Connections to Other BRE Entries

**Connected to BRE-030**

BRE-030 showed AM RF EMF suppression of breast cancer brain metastasis through CACNA1H/CaV3.2 calcium-channel signaling.

BRE-032 strengthens that pathway by showing broader T-type calcium-channel-mediated response to time-varying EMF.

**Connected to BRE-031**

BRE-031 described bioelectric dysregulation across cancer systems, including ion channels and tumor progression.

BRE-032 provides experimental validation that ion-channel signaling can mediate electromagnetic cancer-cell response.

**Connected to BRE-024**

BRE-024 connected ELF-EMF exposure with calcium signaling disruption, ROS generation, and mitochondrial stress in T47D breast cancer cells.

BRE-032 gives a more specific calcium-channel mechanism through T-type channels.

**Connected to BRE-026**

BRE-026 framed membrane potential and ion channels as important in cancer progression.

BRE-032 gives experimental support for targeting that ion-channel layer through electromagnetic exposure.

**Connected to BRE-028 and BRE-029**

BRE-028 and BRE-029 are environmental EMF risk/caution entries.

BRE-032 must remain separate from them because it studies a specific experimental time-varying EMF intervention, not uncontrolled environmental exposure.

***

## Research Gaps Identified

**RG-157: Waveform Specificity and Reproducibility Gap**

Electromagnetic waveform-response relationships remain difficult to compare across laboratories because exposure architecture and waveform normalization are not standardized.

**RG-158: Calcium-Channel Specificity Gap**

More work is needed to determine which T-type calcium-channel subtypes are most responsible for response.

**RG-159: Cross-Cancer Validation Gap**

The study includes multiple cancer models, but broader validation is needed across additional tumor types.

**RG-160: Normal-Cell Safety Gap**

More comparison is needed between malignant and nonmalignant cells under identical exposure conditions.

**RG-161: In-Vivo Translation Gap**

In-vivo tumor suppression was observed, but clinical translation requires standardized dosimetry, replication, and controlled human studies.

***

## Scientific Caution

Electromagnetic waveform-response relationships remain difficult to compare across laboratories because exposure architecture and waveform normalization are not yet standardized.

***

## Why This Entry Matters

For researchers, BRE-032 is important because it gives experimental support to one of the central BREXAtlas ideas: cancer cells may have electromagnetic vulnerabilities mediated by calcium channels.

For patients and families, the simple idea is this:

Some cancer cells may react differently than normal cells when exposed to very specific electromagnetic patterns. This study suggests that calcium channels may explain part of that difference.

This is not proof of a standard treatment. It is a strong experimental signal that deserves careful replication and translation.

***

## Entry Conclusion

BRE-032 is a major validation entry in the BREXAtlas Encyclopedia.

BRE-030 showed CACNA1H/CaV3.2 calcium-channel involvement in breast cancer brain metastasis response.

BRE-031 provided a systems framework for bioelectric cancer behavior.

BRE-032 experimentally supports the idea that specific EMF patterns can inhibit malignant-cell growth through T-type calcium channels.

The central question emerging from this entry is:

Can cancer cells be selectively weakened by designing electromagnetic patterns that activate calcium-channel vulnerability?

For BREXAtlas, BRE-032 is a foundation for the future Frequency / Waveform / Calcium-Channel Response Index.


---

# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.

## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:

```
GET https://www.brexatlas.org/bre-001/bre-032.md?ask=<question>&goal=<endgoal>
```

`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.

The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.
